SCHEMBL22737017

SCHEMBL22737017

N#Cc1cccc(C#N)c1-c1ccc2c(c1)c1c(-c3c(C#N)cccc3C#N)cccc1n2-c1ccc2c(c1)c1ccccc1n2-c1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR3C1 P04150 1/20 0.34
ALDH1A1 P00352 4/20 0.33
MAPK1 P28482 3/20 0.33
HDAC4 P56524 1/20 0.33
LMNA P02545 1/20 0.33
HPGD P15428 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
GABRA1 P14867 1/20 0.32
GABRG2 P18507 1/20 0.32
GABRB3 P28472 1/20 0.32
GABRA5 P31644 1/20 0.32
GABRA3 P34903 1/20 0.32
JAK2 O60674 1/20 0.32
JAK3 P52333 1/20 0.32
PDE10A Q9Y233 1/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22737018 0.96 NR3C1 (0.39) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737447 0.94 KDM4E (0.36) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737259 0.94 KDM4E (0.38) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737244 0.94 KDM4E (0.38) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737704 0.93 KDM4E (0.44) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737262 0.92 NR3C1 (0.35) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737470 0.92 KDM4E (0.45) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737221 0.92 KDM4E (0.47) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737285 0.92 KDM4E (0.47) KDM4EATML3MBTL1NR3C1ALDH1A1
SCHEMBL22737468 0.91 KDM4E (0.41) KDM4EATML3MBTL1NR3C1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377490-A1 CONDENSED CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME, AND ELECTRONIC DEVICE INCLUDING ORGANIC LIGHT-EMITTING DEVICE CCNE2, CRY2, PER2 KDM4E 3559/4885ATM 1504/4885L3MBTL1 2024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.